• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过用OspA、OspB或OspC进行主动免疫,而非用OspD或83千道尔顿抗原,可保护C3H/HeN小鼠免受伯氏疏螺旋体攻击。

Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.

作者信息

Probert W S, LeFebvre R B

机构信息

Department of Pathology, Microbiology, and Immunology, School of Veterinary Medicine, University of California at Davis 95616.

出版信息

Infect Immun. 1994 May;62(5):1920-6. doi: 10.1128/iai.62.5.1920-1926.1994.

DOI:10.1128/iai.62.5.1920-1926.1994
PMID:8168958
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC186442/
Abstract

Recent advances in the development of animal models for Lyme borreliosis have provided means of identifying potential targets for the design of a subunit vaccine to prevent this disease. The C3H/HeN mouse model was used to study several Borrelia burgdorferi antigens from a single isolate for their ability to elicit borreliacidal and protective antibodies. The ospA, ospB, ospC, ospD, and 83-kDa genes from a California isolate, SON 188, were cloned and expressed in Escherichia coli as proteins fused to the C-terminal end of maltose-binding protein. Active immunization of mice with these fusion proteins elicited high titers of antibodies that recognized the homologous SON 188 antigens upon immunoblotting. Antibodies generated to the OspA and OspB fusion proteins, but not to the OspC, OspD, and the 83-kDa fusion proteins, demonstrated in vitro borreliacidal activity. Challenge of all actively immunized mice with 10(7) SON 188 spirochetes resulted in infection in all mice receiving the OspD or 83-kDa immunogens but not in any mice receiving the OspA, OspB, or OspC fusion proteins. These results demonstrate the potential of OspA, OspB, and OspC as components of a subunit vaccine for the prevention of Lyme borreliosis.

摘要

莱姆病动物模型开发的最新进展为确定用于设计预防该疾病的亚单位疫苗的潜在靶点提供了方法。C3H/HeN小鼠模型被用于研究来自单一分离株的几种伯氏疏螺旋体抗原引发杀螺旋体抗体和保护性抗体的能力。来自加利福尼亚分离株SON 188的ospA、ospB、ospC、ospD和83-kDa基因被克隆,并在大肠杆菌中作为与麦芽糖结合蛋白C末端融合的蛋白质表达。用这些融合蛋白对小鼠进行主动免疫可引发高滴度抗体,这些抗体在免疫印迹时能识别同源SON 188抗原。针对OspA和OspB融合蛋白产生的抗体,而非针对OspC、OspD和83-kDa融合蛋白产生的抗体,表现出体外杀螺旋体活性。用10⁷个SON 188螺旋体对所有主动免疫的小鼠进行攻击,结果显示,接受OspD或83-kDa免疫原的所有小鼠均被感染,而接受OspA、OspB或OspC融合蛋白的小鼠均未感染。这些结果证明了OspA、OspB和OspC作为预防莱姆病亚单位疫苗成分的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/186442/aa8c1b7285a0/iai00005-0431-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/186442/daaba51bccc6/iai00005-0430-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/186442/aa8c1b7285a0/iai00005-0431-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/186442/daaba51bccc6/iai00005-0430-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e948/186442/aa8c1b7285a0/iai00005-0431-a.jpg

相似文献

1
Protection of C3H/HeN mice from challenge with Borrelia burgdorferi through active immunization with OspA, OspB, or OspC, but not with OspD or the 83-kilodalton antigen.通过用OspA、OspB或OspC进行主动免疫,而非用OspD或83千道尔顿抗原,可保护C3H/HeN小鼠免受伯氏疏螺旋体攻击。
Infect Immun. 1994 May;62(5):1920-6. doi: 10.1128/iai.62.5.1920-1926.1994.
2
Oral delivery of purified lipoprotein OspA protects mice from systemic infection with Borrelia burgdorferi.口服纯化的脂蛋白OspA可保护小鼠免受伯氏疏螺旋体的全身感染。
Vaccine. 1997 Apr-May;15(6-7):739-46. doi: 10.1016/s0264-410x(97)00219-3.
3
Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi.用外表面蛋白(Osp)A而非OspC进行免疫接种,可为受到北美伯氏疏螺旋体分离株攻击的小鼠提供交叉保护。
J Infect Dis. 1997 Feb;175(2):400-5. doi: 10.1093/infdis/175.2.400.
4
Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.两种不同伯氏疏螺旋体疫苗中重组OspA的免疫反应特征及其与功能参数的关系。
BMC Vet Res. 2018 Oct 16;14(1):312. doi: 10.1186/s12917-018-1625-7.
5
DNA vaccines expressing a fusion product of outer surface proteins A and C from Borrelia burgdorferi induce protective antibodies suitable for prophylaxis but Not for resolution of Lyme disease.表达来自伯氏疏螺旋体的外表面蛋白A和C融合产物的DNA疫苗可诱导产生适合预防但不适合治疗莱姆病的保护性抗体。
Infect Immun. 2001 Apr;69(4):2130-6. doi: 10.1128/IAI.69.4.2130-2136.2001.
6
Impact of the saponin adjuvant QS-21 and aluminium hydroxide on the immunogenicity of recombinant OspA and OspB of Borrelia burgdorferi.皂苷佐剂QS-21和氢氧化铝对伯氏疏螺旋体重组OspA和OspB免疫原性的影响。
Vaccine. 1994 Aug;12(10):925-32. doi: 10.1016/0264-410x(94)90036-1.
7
Resolution of experimental and tick-borne Borrelia burgdorferi infection in mice by passive, but not active immunization using recombinant OspC.通过使用重组OspC进行被动免疫而非主动免疫,可使小鼠实验性感染及蜱传伯氏疏螺旋体感染得到缓解。
Eur J Immunol. 1999 Mar;29(3):946-57. doi: 10.1002/(SICI)1521-4141(199903)29:03<946::AID-IMMU946>3.0.CO;2-P.
8
Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype.针对个别伯氏疏螺旋体分离株或其重组外膜蛋白A(OspA)的免疫血清可保护重症联合免疫缺陷(SCID)小鼠免受同源菌株的感染,但对不同OspA/OspB基因型的菌株只能提供部分保护或完全没有保护作用。
Vaccine. 1993;11(10):1049-54. doi: 10.1016/0264-410x(93)90132-h.
9
Selection of variant Borrelia burgdorferi isolates from mice immunized with outer surface protein A or B.从用外表面蛋白A或B免疫的小鼠中选择变异型伯氏疏螺旋体分离株。
Infect Immun. 1995 May;63(5):1658-62. doi: 10.1128/iai.63.5.1658-1662.1995.
10
Lyme borreliosis in transgenic mice tolerant to Borrelia burgdorferi OspA or B.对伯氏疏螺旋体OspA或OspB耐受的转基因小鼠中的莱姆病螺旋体病
J Clin Invest. 1995 Oct;96(4):1706-14. doi: 10.1172/JCI118215.

引用本文的文献

1
radiosensitivity and Mn antioxidant content: antigenic preservation and pathobiology.放射敏感性与锰抗氧化剂含量:抗原保存与病理生物学
mBio. 2025 Feb 5;16(2):e0313124. doi: 10.1128/mbio.03131-24. Epub 2024 Dec 27.
2
Novel recombinant vaccinia virus-vectored vaccine affords complete protection against homologous infection in mice.新型重组痘苗病毒载体疫苗为小鼠同源感染提供完全保护。
Emerg Microbes Infect. 2024 Dec;13(1):2399949. doi: 10.1080/22221751.2024.2399949. Epub 2024 Oct 11.
3
Antibody-mediated immunological memory correlates with long-term Lyme veterinary vaccine protection in mice.

本文引用的文献

1
Protective immunity in lyme borreliosis.
Parasitol Today. 1993 Apr;9(4):129-31. doi: 10.1016/0169-4758(93)90176-g.
2
Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans.恒河猴莱姆病的早期和早期播散阶段:人类感染的模型
Infect Immun. 1993 Jul;61(7):3047-59. doi: 10.1128/iai.61.7.3047-3059.1993.
3
Variability of osp genes and gene products among species of Lyme disease spirochetes.莱姆病螺旋体不同物种间osp基因及基因产物的变异性。
抗体介导的免疫记忆与小鼠的长期莱姆兽医疫苗保护相关。
Vaccine. 2024 Oct 24;42(24):126084. doi: 10.1016/j.vaccine.2024.06.051. Epub 2024 Jun 26.
4
Structural Elucidation of a Protective B Cell Epitope on Outer Surface Protein C (OspC) of the Lyme Disease Spirochete, Borreliella burgdorferi.结构解析伯氏疏螺旋体(Borrelia burgdorferi)外表面蛋白 C(OspC)上的保护性 B 细胞表位。
mBio. 2023 Apr 25;14(2):e0298122. doi: 10.1128/mbio.02981-22. Epub 2023 Mar 28.
5
Past, present, and future of Lyme disease vaccines: antigen engineering approaches and mechanistic insights.莱姆病疫苗的过去、现在和未来:抗原工程方法和机制见解。
Expert Rev Vaccines. 2022 Oct;21(10):1405-1417. doi: 10.1080/14760584.2022.2102484. Epub 2022 Jul 22.
6
Host Specialisation, Immune Cross-Reaction and the Composition of Communities of Co-circulating Borrelia Strains.宿主特化、免疫交叉反应与共循环伯氏疏螺旋体菌株群落的组成。
Bull Math Biol. 2021 May 3;83(6):66. doi: 10.1007/s11538-021-00896-2.
7
Human and Veterinary Vaccines for Lyme Disease.人用和兽用莱姆病疫苗。
Curr Issues Mol Biol. 2021;42:191-222. doi: 10.21775/cimb.042.191. Epub 2020 Dec 8.
8
Development and optimization of OspC chimeritope vaccinogens for Lyme disease.开发和优化莱姆病 OspC 嵌合表位疫苗原。
Vaccine. 2020 Feb 18;38(8):1915-1924. doi: 10.1016/j.vaccine.2020.01.027. Epub 2020 Jan 17.
9
Comparative vector competence of North American Lyme disease vectors.比较北美的莱姆病传播媒介的媒介效能。
Parasit Vectors. 2020 Jan 14;13(1):29. doi: 10.1186/s13071-020-3893-x.
10
Design of a Lyme Disease Vaccine as an Active Learning Approach in a Novel Interdisciplinary Graduate-Level Course.作为一门新型跨学科研究生课程中主动学习方法的莱姆病疫苗设计
J Microbiol Biol Educ. 2017 Oct 4;18(3). doi: 10.1128/jmbe.v18i3.1304. eCollection 2017.
Infect Immun. 1993 Jun;61(6):2611-7. doi: 10.1128/iai.61.6.2611-2617.1993.
4
Regulation of expression of major outer surface proteins in Borrelia burgdorferi.伯氏疏螺旋体主要外表面蛋白表达的调控
Infect Immun. 1993 May;61(5):2207-10. doi: 10.1128/iai.61.5.2207-2210.1993.
5
Experimental Lyme disease in dogs produces arthritis and persistent infection.犬类实验性莱姆病会引发关节炎和持续性感染。
J Infect Dis. 1993 Mar;167(3):651-64. doi: 10.1093/infdis/167.3.651.
6
Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test.人类对伯氏疏螺旋体的杀螺旋体抗体反应的特征:一项血清诊断试验。
J Infect Dis. 1993 Jan;167(1):158-64. doi: 10.1093/infdis/167.1.158.
7
Seroprotective groups among isolates of Borrelia burgdorferi.伯氏疏螺旋体分离株中的血清保护组。
Infect Immun. 1993 Oct;61(10):4367-74. doi: 10.1128/iai.61.10.4367-4374.1993.
8
Isolation and analysis of a linear plasmid-located gene of Borrelia burgdorferi B29 encoding a 27 kDa surface lipoprotein (P27) and its overexpression in Escherichia coli.伯氏疏螺旋体B29线性质粒定位基因的分离与分析,该基因编码一种27 kDa表面脂蛋白(P27)及其在大肠杆菌中的过表达。
Mol Microbiol. 1993 Jun;8(6):1115-24. doi: 10.1111/j.1365-2958.1993.tb01656.x.
9
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine.表达外表面蛋白A(OspA)脂蛋白的重组卡介苗(BCG)引发的保护性免疫:一种莱姆病候选疫苗。
J Exp Med. 1993 Jul 1;178(1):197-209. doi: 10.1084/jem.178.1.197.
10
Distribution and molecular analysis of Lyme disease spirochetes, Borrelia burgdorferi, isolated from ticks throughout California.从加利福尼亚州各地蜱虫中分离出的莱姆病螺旋体——伯氏疏螺旋体的分布及分子分析
J Clin Microbiol. 1993 Dec;31(12):3096-108. doi: 10.1128/jcm.31.12.3096-3108.1993.